Cedobact CV 200mg/125mg Tablet DT
By Cedobact CV
Rx
6 Tablet DT in a Strip

Composition
Cefpodoxime Proxetil(200mg) + Clavulanic Acid(125mg)

Manufacturer - Biofield Pharma
S.C.F. No. 377, M.Market, Manimajra

Expires on or after
June, 2026

liver
There is limited information available about the use of Cedobact CV 200mg/125mg Tablet DT in patients with liver disease. It is important to consult your doctor before using this medication if you have any liver issues. Your doctor will be able to provide guidance tailored to your specific situation.

kidney
Cedobact CV 200mg/125mg Tablet DT should be used cautiously in individuals with severe kidney disease. Adjusting the dosage might be necessary in such cases. It is advised to seek guidance from a healthcare professional before using this medication.

alcohol
Consult doctor before consuming alcohol with Cedobact CV 200mg/125mg Tablet DT.

driving
Cedobact CV 200mg/125mg Tablet DT may cause side effects like allergic reactions, dizziness, or fits that could affect driving ability. Refrain from driving if experiencing symptoms impairing focus and reaction time when using this medication.

pregnancy
Cedobact CV 200mg/125mg Tablet DT is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Cedobact CV 200mg/125mg Tablet DT is confirmed safe for breastfeeding mothers. Studies show it does not transfer to breastmilk in harmful quantities, posing no risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | - |
₹238.5
₹265
10% OFF
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
